Expression of multiple catechol‐o‐methyltransferase (COMT) mRNA variants in human brain

Elizabeth M. Tunbridge1,2, Tracy Lane2, Paul J. Harrison2
1Department of Pharmacology, Oxford University, Oxford, United Kingdom
2Department of Psychiatry, Oxford University, Oxford, United Kingdom

Tóm tắt

AbstractCatechol‐o‐methyltransferase (COMT) is important for modulating dopamine levels, prefrontal cortex (PFC) function, and several psychiatric phenotypes. A single COMT mRNA has been described in human brain, which gives rise to membrane‐bound (MB)‐ and soluble (S)‐COMT proteins. In addition, we have recently described a novel COMT protein isoform in the human PFC, suggesting that there are more COMT gene products expressed than are currently appreciated. Therefore, we have investigated whether variant COMT mRNAs are present in human brain. We used reverse transcription‐PCR (RT‐PCR) to screen systematically for variant COMT mRNAs in human frontal cortex. Intron‐spanning primers were used for exon‐to‐exon PCR reactions; additionally, specific primers were designed to sequences in the NCBI Aceview database. The identity of amplicons was confirmed by sequencing, and their regional distributions and 3′ untranslated regions (UTRs) were characterised using RT‐PCR. We detected 7 COMT variant mRNAs, resulting from both insertions and deletions within the known COMT brain transcript. Several of the variants alter the predicted coding sequence. Three of these variants correspond to sequences within the Aceview database and could be reliably amplified, while the remaining four do not correspond to any expressed sequence tags and were amplified only once. The regional distributions of these transcripts are described. The results demonstrate multiple COMT mRNAs in human brain, revealing an additional complexity to the biology of COMT. The alternate gene products may be of significant functional importance, and differentially impacted by polymorphisms within the COMT gene. © 2007 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1021/bi962590c

10.1086/376578

10.1086/425589

10.1016/j.gene.2006.09.028

10.1073/pnas.111134598

10.1093/nar/gkg563

10.1073/pnas.95.17.9991

10.1001/archpsyc.60.9.889

10.1016/S0165-0173(99)00045-4

10.1097/00001756-199808240-00033

10.1016/j.pharmthera.2004.11.001

10.1001/archpsyc.59.7.662

10.1097/00008571-199606000-00007

10.1073/pnas.0602002103

10.1021/bi00013a008

Mannisto PT, 1999, Catechol‐O‐methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors, Pharmacol Rev, 51, 593

10.1016/S0306-4522(02)00556-0

10.1016/j.tins.2006.02.005

10.1038/sj.mp.4001860

10.1016/S0896-6273(03)00676-7

10.1126/science.1131262

Pedersen AG, 1997, Neural network prediction of translation initiation sites in eukaryotes: Perspectives for EST and genome analysis, Intell Syst Mol Biol, 5, 226

10.1007/BFb0036121

10.1038/sj.mp.4001386

10.1111/j.1432-1033.1994.tb19083.x

10.1002/syn.10286

10.1523/JNEUROSCI.1124-04.2004

10.1016/j.biopsych.2005.10.024

Tunbridge EM, Catechol‐o‐methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan, Cereb Cortex

10.1038/sj.mp.4001767

10.1016/S0006-3223(01)01252-5